Michael B. Lilly
Impact in
- Pathology and Forensic Medicine top 0.5%
- Cancer Mechanisms and Therapy
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
Papers in
- Oncology 33
- Peptidase Inhibition and Analysis 15
- Hematology 17
- Chronic Myeloid Leukemia Treatments 9
- Multiple Myeloma Research and Treatments 6
- Co-authors
- Andrew S. Kraft (16 shared papers)Marina Zemskova (10 shared papers)Päivi J. Koskinen (3 shared papers)Jouko A. Sandholm (2 shared papers)Sheldon L. Holder (4 shared papers)Katriina Johanna Peltola (1 shared paper)Harri Mankonen (1 shared paper)Matthew Robert Janes (5 shared papers)
- Journals
- Blood (6 papers)Journal of Biological Chemistry (5 papers)Molecular Cancer Therapeutics (3 papers)Journal of Clinical Investigation (3 papers)Oncotarget (3 papers)
- Partner nations
- United StatesChinaSingapore
In The Last Decade
Michael B. Lilly
95 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 129
- Pathology and Forensic Medicine 1.5k
- Hematology 648
- Oncology 1.3k
- Cancer Research 625
- Molecular Biology 2.4k
Countries citing papers authored by Michael B. Lilly
This map shows the geographic impact of Michael B. Lilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael B. Lilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael B. Lilly more than expected).
Fields of papers citing papers by Michael B. Lilly
This network shows the impact of papers produced by Michael B. Lilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael B. Lilly. The network helps show where Michael B. Lilly may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael B. Lilly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 299 | |
| 2 | 2004 | 291 | |
| 3 | 2012 | 278 | |
| 4 | 2003 | 224 | |
| 5 | 2004 | 199 | |
| 6 | 2007 | 168 | |
| 7 | 1999 | 149 | |
| 8 | 2005 | 137 | |
| 9 | 2008 | 130 | |
| 10 | 2008 | 129 | |
| 11 | 2009 | 122 | |
| 12 | 2008 | 112 | |
| 13 | 2020 | 108 | |
| 14 | 2009 | 108 | |
| 15 | 2018 | 97 | |
| 16 | 2012 | 94 | |
| 17 | Local hyperthermia with interstitial techniques. | 1984 | 89 |
| 18 | 2009 | 89 | |
| 19 | Enforced expression of the Mr 33,000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells. | 1997 | 85 |
| 20 | 2015 | 85 |
About Michael B. Lilly
Michael B. Lilly is a scholar working on Oncology, Hematology, Pathology and Forensic Medicine, Cancer Research and Pulmonary and Respiratory Medicine, having authored 96 papers that have together received 5.0k indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (17 papers), Prostate Cancer Treatment and Research (16 papers), Peptidase Inhibition and Analysis (15 papers), Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (7 papers), Prostate Cancer Diagnosis and Treatment (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Immune Response and Inflammation (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.5k citations), Hematology (648 citations), Oncology (1.3k citations), Cancer Research (625 citations) and Molecular Biology (2.4k citations). Michael B. Lilly has collaborated with scholars based in United States, China and Singapore. Frequent co-authors include Andrew S. Kraft, Marina Zemskova, Päivi J. Koskinen, Jouko A. Sandholm, Sheldon L. Holder, Katriina Johanna Peltola, Harri Mankonen, Matthew Robert Janes, Ivan A Brezovich and Eva Sahakian. Their work appears in journals such as Blood, Journal of Biological Chemistry, Molecular Cancer Therapeutics, Journal of Clinical Investigation and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.